These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2696023)

  • 1. The Milan experience with adjuvant chemotherapy in premenopausal breast cancer.
    Bonadonna G; Valagussa P; Zambetti M; Brambilla C
    Recent Results Cancer Res; 1989; 115():113-7. PubMed ID: 2696023
    [No Abstract]   [Full Text] [Related]  

  • 2. Scottish adjuvant breast cancer trials: results in pre-menopausal patients.
    Stewart HJ
    Recent Results Cancer Res; 1989; 115():126-31. PubMed ID: 2696025
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant chemo- and endocrine therapy alone or in combination in premenopausal patients (GABG Trial 1).
    Kaufmann M; Jonat W; Abel U
    Recent Results Cancer Res; 1989; 115():118-25. PubMed ID: 2696024
    [No Abstract]   [Full Text] [Related]  

  • 4. Significant survival benefit of node-negative breast cancer patients treated with adjuvant chemotherapy: seven-year results.
    Jakesz R; Reiner G; Schemper M; Reiner A; Blijham G; Rainer H; Dittrich D; Spona J; Schutte B; Reynders M
    Recent Results Cancer Res; 1989; 115():180-5. PubMed ID: 2696031
    [No Abstract]   [Full Text] [Related]  

  • 5. Adriamycin, vincristine, cyclophosphamide and 5-fluorouracil (AVCF) compared with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in premenopausal breast carcinoma. Personal results.
    Mathé G; Misset JL; Plagne R; Reizenstein P; Belpomme D; Le Mevel B; Guerrin J; Fumoleau P; Metz R; Delgado M
    Drugs Exp Clin Res; 1986; 12(1-3):143-5. PubMed ID: 3525068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy for node-negative breast cancer patients.
    Bonadonna G; Zambetti M; Valagussa P
    Recent Results Cancer Res; 1989; 115():175-9. PubMed ID: 2516350
    [No Abstract]   [Full Text] [Related]  

  • 7. Critical review of adjuvant therapy in premenopausal patients.
    Mouridsen HT
    Recent Results Cancer Res; 1989; 115():132-5. PubMed ID: 2623330
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjuvant oophorectomy versus CMF in premenopausal node-positive breast cancer: long-term results of an experience at the Milan Cancer Institute.
    Salvadori B; Celio L; Oriana R; Bajetta E
    Tumori; 2000; 86(3):258-9. PubMed ID: 10939610
    [No Abstract]   [Full Text] [Related]  

  • 9. How to improve adjuvant treatment results in postmenopausal patients.
    Mouridsen HT
    Recent Results Cancer Res; 1989; 115():144-52. PubMed ID: 2533698
    [No Abstract]   [Full Text] [Related]  

  • 10. Endocrine effects of adjuvant chemotherapy in premenopausal women: suggestions for the future.
    Tormey DC
    Recent Results Cancer Res; 1989; 115():106-12. PubMed ID: 2623329
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjuvant chemo-endocrine therapy or endocrine therapy alone for postmenopausal patients: Ludwig Studies III and IV.
    Goldhirsch A; Gelber RD
    Recent Results Cancer Res; 1989; 115():153-62. PubMed ID: 2696027
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjuvant chemotherapy of breast cancer: a promising experiment or standard practice?
    Henderson IC
    J Clin Oncol; 1985 Feb; 3(2):140-3. PubMed ID: 3881560
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemo- or endocrine adjuvant therapy alone or combined in postmenopausal patients (GABG Trial 1).
    Jonat W; Kaufmann M; Abel U
    Recent Results Cancer Res; 1989; 115():163-9. PubMed ID: 2696028
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjuvant chemotherapy for breast cancer. Implications of clinical trials.
    Carter SK
    Postgrad Med; 1985 Jan; 77(1):75-7, 80-3. PubMed ID: 3880891
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvant systemic therapy for resectable breast cancer.
    Bonadonna G; Valagussa P
    J Clin Oncol; 1985 Feb; 3(2):259-75. PubMed ID: 3881562
    [No Abstract]   [Full Text] [Related]  

  • 16. CMF adjuvant programs at the Milan Cancer Institute.
    Bonadonna G; Rossi A; Tancini G; Valagussa P; Veronesi U
    Recent Results Cancer Res; 1984; 96():66-73. PubMed ID: 6549356
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjuvant therapy of premenopausal and menopausal high-risk breast cancer patients. Present status of the Danish Breast Cancer Cooperative Group Trials 77-B and 82-B.
    Dombernowsky P; Brincker H; Hansen M; Mouridsen HT; Overgaard M; Panduro J; Rose C; Axelsson CK; Andersen J; Andersen KW
    Acta Oncol; 1988; 27(6A):691-7. PubMed ID: 3064774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized perioperative therapy in operable breast cancer: the Ludwig Trial V.
    Goldhirsch A; Gelber RD
    Recent Results Cancer Res; 1989; 115():43-53. PubMed ID: 2696040
    [No Abstract]   [Full Text] [Related]  

  • 19. [Randomized trial on the effect of radiotherapy in addition to 6 cycles CMF in node-positive breast cancer].
    Noël G; Mazeron JJ
    Cancer Radiother; 2001 Apr; 5(2):206-7. PubMed ID: 11355592
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant chemo-endocrine therapy in postmenopausal women with breast cancer and axillary-node metastases.
    Goldhirsch A; Castiglione M; Gelber RD
    Lancet; 1990 May; 335(8697):1099-100. PubMed ID: 1970400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.